Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Comabella

Showing results (131-140 of 244) with videos related to

Pageof 25
Sort By:
Journal of Neuroimmunology|October 25, 2003
A genomic screen of Spanish multiple sclerosis patients reveals multiple loci associated with the diseaseRobert Goertsches, Pablo Villoslada, Manuel Comabella, et al.
Neurology|July 18, 2020
Serum neurofilament light as a biomarker in progressive multiple sclerosisRaju Kapoor, Kathryn E Smith, Mark Allegretta, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2017
Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factorGeorgina Arrambide, Alex Rovira, Jaume Sastre-Garriga, et al.
Human Molecular Genetics|January 28, 2022
Identification of the genetic mechanism that associates L3MBTL3 to multiple sclerosisAntonio Alcina, Maria Fedetz, Isabel Vidal-Cobo, et al.
Brain : a Journal of Neurology|February 21, 2018
The value of oligoclonal bands in the multiple sclerosis diagnostic criteriaGeorgina Arrambide, Mar Tintore, Carmen Espejo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 10, 2017
NLRP3 polymorphisms and response to interferon-beta in multiple sclerosis patientsSunny Malhotra, Melissa Sorosina, Jordi Río, et al.
Plos One|August 15, 2015
Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-AnalysisMiguel A Ortiz, Concepción Núñez, David Ordóñez, et al.
Frontiers in Immunology|October 16, 2023
Teriflunomide and Epstein-Barr virus in a Spanish multiple sclerosis cohort: <i>in vivo</i> antiviral activity and clinical responseMaría Inmaculada Domínguez-Mozo, Inés González-Suárez, Luisa María Villar, et al.
Brain : a Journal of Neurology|April 23, 2015
Defining high, medium and low impact prognostic factors for developing multiple sclerosisMar Tintore, Àlex Rovira, Jordi Río, et al.
Revista De Neurologia|March 23, 2013
[Biomarkers in multiple sclerosis]Óscar Fernández, Rafael Arroyo-González, Alfredo Rodríguez-Antigüedad, et al.
Pageof 25

Showing results (131-140 of 244) with videos related to

Sort By:
Pageof 25
Journal of Neuroimmunology|October 25, 2003
A genomic screen of Spanish multiple sclerosis patients reveals multiple loci associated with the diseaseRobert Goertsches, Pablo Villoslada, Manuel Comabella, et al.
Neurology|July 18, 2020
Serum neurofilament light as a biomarker in progressive multiple sclerosisRaju Kapoor, Kathryn E Smith, Mark Allegretta, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2017
Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factorGeorgina Arrambide, Alex Rovira, Jaume Sastre-Garriga, et al.
Human Molecular Genetics|January 28, 2022
Identification of the genetic mechanism that associates L3MBTL3 to multiple sclerosisAntonio Alcina, Maria Fedetz, Isabel Vidal-Cobo, et al.
Brain : a Journal of Neurology|February 21, 2018
The value of oligoclonal bands in the multiple sclerosis diagnostic criteriaGeorgina Arrambide, Mar Tintore, Carmen Espejo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 10, 2017
NLRP3 polymorphisms and response to interferon-beta in multiple sclerosis patientsSunny Malhotra, Melissa Sorosina, Jordi Río, et al.
Plos One|August 15, 2015
Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-AnalysisMiguel A Ortiz, Concepción Núñez, David Ordóñez, et al.
Frontiers in Immunology|October 16, 2023
Teriflunomide and Epstein-Barr virus in a Spanish multiple sclerosis cohort: <i>in vivo</i> antiviral activity and clinical responseMaría Inmaculada Domínguez-Mozo, Inés González-Suárez, Luisa María Villar, et al.
Brain : a Journal of Neurology|April 23, 2015
Defining high, medium and low impact prognostic factors for developing multiple sclerosisMar Tintore, Àlex Rovira, Jordi Río, et al.
Revista De Neurologia|March 23, 2013
[Biomarkers in multiple sclerosis]Óscar Fernández, Rafael Arroyo-González, Alfredo Rodríguez-Antigüedad, et al.
Pageof 25